Cemiplimab (Patient)
Medication Basics
Drug Name
Cemiplimab (Brand names: Libtayo®)
Purpose / Indication
Used to treat certain cancers such as cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer, and other approved indications.
Dosage & Administration
Dose Schedule
Commonly administered as an intravenous infusion every 3 weeks, though dosing and duration must follow the oncology provider’s treatment plan and current protocol.
Route
IV (Intravenous)
Timing Considerations
Treatment is given in cycles. The infusion schedule is determined by the oncology team and may change if side effects occur.
Time of Day
Flexible
Special Instructions
Keep all appointments and tell your care team about new symptoms before each treatment.
Injection Techniques
This medicine is given by trained healthcare professionals through an IV line.
Mechanism of Action
Mechanism
This medicine helps your immune system recognize and attack cancer cells by blocking a signal that can turn immune cells off.